DEEP-IN-CELL
Financiado
Innovative single-cell RNA-seq kit to support large democratization of insgle-ce...
Innovative single-cell RNA-seq kit to support large democratization of insgle-cell analysis
This project will develop and perform the industrial scale-up of a game-changing scRNA-seq tool named DEEP-IN-CELL. This solution, in a kit format plus a cloud software analysis suite, will use the proprietary hydrogel-based RevGe...
This project will develop and perform the industrial scale-up of a game-changing scRNA-seq tool named DEEP-IN-CELL. This solution, in a kit format plus a cloud software analysis suite, will use the proprietary hydrogel-based RevGel technology of Asteria kit as a basis for a new generation of kit that ambitions to dramatically simplify access to single-cell studies with a shorter time to result, far easier, robust and authentic transcriptome-preserving technology multiplied by reducing cost per sample. This new generation of kit shall bring a similar revolution to the single-cell market as did the Qiagen RNA extraction kit in its time to the genomic market, while providing performances at par with that of the market gold standard and monopolistic costive instrument-based single-cell technology 10xGenomics.
This next generation of single-cell RNAseq kit is expected to first launch in late 2024 with first applications to the international single-cell research market and to generate sales exceeding €50M by 2029. It is foreseen to become the quintessencial single-cell RNAseq kit that will open access to single-cell studies to a much broader research community.
ver más
Duración del proyecto: 36 meses
Fecha Inicio: 2022-12-16
Fecha Fin: 2025-12-31
Fecha Fin: 2025-12-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-12-16
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2022-ACCELERATOROPEN-01:
EIC Accelerator Open
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
3M€
Líder del proyecto
SCIPIO BIOSCIENCE
No se ha especificado una descripción o un objeto social para esta compañía.
